In vitro assays of angiogenesis typically study the behavior of endothelial cells within a controlled environment. Fundamentally, these in vitro studies are based on purified endothelial cell cultures or carefully controlled co-culture with another cell type (i.e., fibroblasts, immune cells, pericytes, tumor cells).
This report contains market size and forecasts of Angiogenesis Assay Kit in global, including the following market information:
Global Angiogenesis Assay Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiogenesis Assay Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Angiogenesis Assay Kit companies in 2021 (%)
The global Angiogenesis Assay Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Angiogenesis Activation Assay Kit Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiogenesis Assay Kit include Thermo Fisher Scientific, Abcam, PromoCell GmbH, Merck KGaA, Trevigen and Kollodis BioSciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiogenesis Assay Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiogenesis Assay Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiogenesis Assay Kit Market Segment Percentages, by Type, 2021 (%)
Angiogenesis Activation Assay Kit
Angiogenesis Inhibition Assay Kit
Global Angiogenesis Assay Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiogenesis Assay Kit Market Segment Percentages, by Application, 2021 (%)
Academic Institution
Biotech Companies
Global Angiogenesis Assay Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiogenesis Assay Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiogenesis Assay Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiogenesis Assay Kit revenues share in global market, 2021 (%)
Key companies Angiogenesis Assay Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Angiogenesis Assay Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Abcam
PromoCell GmbH
Merck KGaA
Trevigen
Kollodis BioSciences